Department of Plastic and Reconstructive Surgery, Northwestern University, Chicago, Illinois.
Section of Plastic and Reconstructive Surgery, University of Michigan, Ann Arbor, Michigan.
J Am Acad Dermatol. 2018 Mar;78(3):560-578. doi: 10.1016/j.jaad.2017.10.007. Epub 2018 Jan 10.
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.
皮肤鳞状细胞癌(cSCC)是第二常见的人类癌症,其发病率呈逐年上升趋势。尽管大多数 cSCC 可通过门诊治疗治愈,但晚期 cSCC 仍存在较高的发病率、对生活质量的影响和死亡风险。本文件为 cSCC 患者的管理提供了循证建议。所涉及的主题包括活检技术和组织病理学评估、肿瘤分期、手术和非手术治疗、随访和预防复发,以及晚期疾病的管理。这些建议的主要重点是评估和管理原发性 cSCC 和局限性疾病,但在相关情况下,也指出了这些建议在复发性 cSCC 中的适用性,并提供了有关转移性疾病患者管理的一般信息。